[MYGN] YoY Quarter Result on 31-Dec-2017 [#Q4]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
07-Feb-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -60.42%
YoY- 444.07%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 154,600 195,100 216,800 194,000 196,500 193,300 184,393 -2.89%
PBT -55,700 -11,400 3,600 3,700 12,100 45,000 37,940 -
Tax -11,500 -3,100 1,000 -28,400 6,200 14,700 13,909 -
NP -44,200 -8,300 2,600 32,100 5,900 30,300 24,031 -
Tax Rate - - -27.78% 767.57% -51.24% -32.67% -36.66% -
Total Cost 198,800 203,400 214,200 161,900 190,600 163,000 160,362 3.64%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -28.59 -4.25 1.20 16.55 3.00 15.68 13.03 -
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -0.59 -0.11 0.04 0.46 0.09 0.43 0.33 -
EPS Diluted -0.59 -0.11 0.03 0.45 0.09 0.41 0.32 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.